GLSI
Price
$12.39
Change
-$0.13 (-1.04%)
Updated
Dec 20 closing price
67 days until earnings call
SCPH
Price
$3.39
Change
+$0.08 (+2.42%)
Updated
Dec 20, 04:59 PM (EDT)
88 days until earnings call
Ad is loading...

GLSI vs SCPH

Header iconGLSI vs SCPH Comparison
Open Charts GLSI vs SCPHBanner chart's image
Greenwich LifeSciences
Price$12.39
Change-$0.13 (-1.04%)
Volume$72.65K
CapitalizationN/A
scPharmaceuticals
Price$3.39
Change+$0.08 (+2.42%)
Volume$6.59K
CapitalizationN/A
GLSI vs SCPH Comparison Chart
Loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLSI vs. SCPH commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and SCPH is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (GLSI: $12.39 vs. SCPH: $3.39)
Brand notoriety: GLSI and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 253% vs. SCPH: 605%
Market capitalization -- GLSI: $162.86M vs. SCPH: $169.64M
GLSI [@Biotechnology] is valued at $162.86M. SCPH’s [@Biotechnology] market capitalization is $169.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLSI and SCPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 4 TA indicator(s) are bullish while SCPH’s TA Score has 5 bullish TA indicator(s).

  • GLSI’s TA Score: 4 bullish, 5 bearish.
  • SCPH’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SCPH is a better buy in the short-term than GLSI.

Price Growth

GLSI (@Biotechnology) experienced а -8.29% price change this week, while SCPH (@Biotechnology) price change was +6.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

GLSI is expected to report earnings on Feb 26, 2025.

SCPH is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCPH($170M) and GLSI($163M) have the same market capitalization . GLSI YTD gains are higher at: 17.776 vs. SCPH (-45.933). GLSI has higher annual earnings (EBITDA): -10.76M vs. SCPH (-71.31M). SCPH has more cash in the bank: 91.5M vs. GLSI (5.82M). SCPH has higher revenues than GLSI: SCPH (30.3M) vs GLSI (0).
GLSISCPHGLSI / SCPH
Capitalization163M170M96%
EBITDA-10.76M-71.31M15%
Gain YTD17.776-45.933-39%
P/E RatioN/AN/A-
Revenue030.3M-
Total Cash5.82M91.5M6%
Total DebtN/A52.5M-
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSISCPH
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 25 days ago
75%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 5 days ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
63%
N/A
View a ticker or compare two or three
Ad is loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMVQX55.430.58
+1.06%
Nuveen Mid Cap Value 1 R6
SBIIX9.890.02
+0.20%
Sterling Capital Behavioral Intl Eq Inst
JSVQX27.27N/A
N/A
JPMorgan Small Cap Value R4
LIAGX13.90N/A
N/A
Lord Abbett International Growth I
FGRAX49.28-4.61
-8.55%
Franklin Growth Opportunities A

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ETNB. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-1.04%
ETNB - GLSI
36%
Loosely correlated
+12.80%
DNLI - GLSI
35%
Loosely correlated
-0.14%
ORMP - GLSI
35%
Loosely correlated
-4.42%
SLDB - GLSI
32%
Poorly correlated
+3.74%
NAUT - GLSI
32%
Poorly correlated
-0.56%
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with MGTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
+2.42%
MGTX - SCPH
44%
Loosely correlated
+5.31%
AURA - SCPH
43%
Loosely correlated
+1.23%
CDXS - SCPH
43%
Loosely correlated
+3.13%
BEAM - SCPH
43%
Loosely correlated
+8.16%
ABCL - SCPH
43%
Loosely correlated
+4.80%
More